New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
06:14 EDTINTC, SHPGStocks with implied volatility below IV index mean; INTC SHPG
Stocks with implied volatility below IV index mean; Intel (INTC) 17, Shire (SHPG) 18 according to iVolatility.
News For INTC;SHPG From The Last 14 Days
Check below for free stories on INTC;SHPG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 16, 2014
11:51 EDTSHPGOECD looks to close tax loopholes with new proposals
Subscribe for More Information
September 15, 2014
10:55 EDTSHPGRegulators to determine AbbVie, Shire deal by next month, Reuters says
Subscribe for More Information
08:01 EDTSHPGShire announces FDA acceptance for filing of sNDA for Vyvanse
Subscribe for More Information
07:19 EDTINTCSNIA to hold a conference
Subscribe for More Information
September 11, 2014
13:51 EDTINTCIntel tablet AP shipments could reach 7M units in 2H14, Digitimes reports
In the first half of 2014, Intel shipped approximately 1.5M tablet application processors, but Digitimes Research expects the company's shipments to total 7M units in the second half due to China brand vendors' and white-box players' full support, Digitimes reports. Reference Link
07:35 EDTINTCAntitrust suit over tech giants' hiring pushed back, WSJ reports
Subscribe for More Information
September 10, 2014
16:00 EDTINTCIntel acquires Powerwave patent portfolio
Subscribe for More Information
08:37 EDTSHPGMedgenics appoints Scott Applebaum as Chief Legal Officer
Subscribe for More Information
07:37 EDTINTCIntel products look strong, says Wells Fargo
Subscribe for More Information
07:06 EDTSHPGSangamo plans to submit IND application for hemophilia B in 2Q15
Sangamo BioSciences (SGMO) plans to submit an Investigational New Drug application for the treatment of hemophilia B in Q2 2015. This program, partnered with Shire (SHPG), is the first therapeutic application of Sangamo's zinc finger nuclease-mediated In Vivo Protein Replacement Platform. Sangamo is developing the IVPRP as a generally applicable strategy to provide a one-time, permanent genetic cure for monogenic diseases that are currently managed by protein replacement therapy, which involves costly repeat infusions over the lifetime of the patient.
September 9, 2014
14:12 EDTINTCApple confirms wireless charging for Apple Watch
Subscribe for More Information
13:03 EDTINTCIntel head feels expensive tablet chip plan beneficial, Reuters says
Subscribe for More Information
08:51 EDTINTCIntegrated Device says 'working closely' with Intel on wireless charging
Integrated Device Technology (IDTI) announced earlier at the Intel Developer Forum that it is working closely with Intel (INTC) on the development of wireless charging solutions to accelerate the delivery and adoption of the technology. The two companies, both board members of the Alliance for Wireless Power, will define, design and manufacture solutions that comply with the A4WP magnetic resonance standard. The new technology will offer the ability to charge both lower and higher power devices, from wearables and phones to tablets and PCs. The companies expect to have their technology in products in 2015, IDT stated.
07:29 EDTINTCUBM Canon to hold a summit
Subscribe for More Information
07:28 EDTINTCThe Money Event, Inc to hold a conference
Subscribe for More Information
07:17 EDTINTCThe Wireless Association to hold a conference
Subscribe for More Information
07:13 EDTINTCIntel to hold a forum
Annual Developers Forum: IDF 2014 to be held in San Francisco on September 9-11.
07:11 EDTINTCUBM Tech to hold a conference
Subscribe for More Information
September 8, 2014
13:18 EDTINTCIntel 'Grantley' line could drive server processor unit growth, says Wells Fargo
Subscribe for More Information
13:15 EDTINTCIntel introduces Xeon processors for servers
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use